MRSE in Blood Cultures: Contamination vs. True Infection
A single positive blood culture for methicillin-resistant Staphylococcus epidermidis (MRSE) is most likely a contaminant and should not be treated with antibiotics if other blood cultures drawn at the same time are negative.
Clinical Decision Framework
The determination of whether MRSE represents contamination versus true bacteremia follows a clear algorithmic approach based on established guidelines:
When MRSE is Likely a Contaminant
Do NOT treat if:
- Only one blood culture bottle is positive for coagulase-negative staphylococci (including MRSE) when other blood cultures from the same time frame are negative 1
- The patient lacks risk factors for true CoNS bacteremia
- No clinical signs of infection are present
The HICPAC guidelines explicitly state that vancomycin use should be discouraged for "treatment in response to a single blood culture positive for coagulase-negative staphylococcus, if other blood cultures taken during the same time frame are negative (i.e., if contamination of the blood culture is likely)" 1. This reflects the reality that S. epidermidis is normal skin flora and frequently contaminates blood cultures during collection 1, 2.
When MRSE Represents True Bacteremia
Treat if TWO or more blood culture sets are positive for MRSE, particularly when accompanied by:
- Presence of indwelling devices: Central venous catheters, prosthetic heart valves, pacemakers, or other implanted medical devices 3, 4
- Clinical signs: Fever, hemodynamic instability, or catheter site infection 5
- Rising inflammatory markers: Increase in C-reactive protein >35 mg/L over 24 hours from first positive culture 5
- High-risk settings: Hemodialysis patients, neonatal intensive care units, immunocompromised hosts 3, 6
- Recent invasive procedures or nosocomial acquisition 7
Key Clinical Pitfalls
The Multiple Culture Rule
The CDC guidelines for catheter-related infections specify that common skin contaminants (including coagulase-negative staphylococci) require two or more positive blood cultures drawn on separate occasions to meet criteria for laboratory-confirmed bloodstream infection 8. A single positive culture, even with an intravascular line present, does not automatically warrant treatment unless the physician makes a specific clinical judgment 8.
The 3% Contamination Threshold
Blood culture contamination rates should not exceed 3% in any healthcare facility 2. S. epidermidis is explicitly listed as a common blood culture contaminant alongside diphtheroids, Bacillus species, Propionibacterium, and micrococci 8, 9. Laboratories should have abbreviated workup protocols for these organisms when contamination is suspected 2.
Device-Associated Infections
When MRSE is truly pathogenic, it almost always involves biofilm formation on medical devices 4, 10. In adults and children (excluding neonates), if multiple blood cultures are positive for methicillin-resistant CoNS, remove and replace central and arterial lines 3. The exception is neonates, where S. epidermidis is a leading cause of true bloodstream infections in NICUs 6.
Treatment Considerations When Infection is Confirmed
If true MRSE bacteremia is established (multiple positive cultures with clinical correlation):
- Vancomycin remains first-line for most cases 3
- Daptomycin (6-10 mg/kg/dose IV daily) is an alternative, particularly for endocarditis or vancomycin MIC >1 mg/L 3, 7
- Linezolid may be considered in specific circumstances 3
- Duration: Minimum 2 weeks for uncomplicated bacteremia, 4-6 weeks for complicated cases, 6 weeks for endocarditis 11, 12
The Bottom Line
MRSE is usually a contaminant when isolated from a single blood culture. The clinical context—particularly the presence of indwelling devices, multiple positive cultures, and clinical signs of infection—determines whether treatment is warranted. Overtreatment of contaminants drives unnecessary antibiotic use, promotes resistance, increases healthcare costs, and exposes patients to drug toxicity 1, 13. The safest approach is to obtain proper blood culture technique (using chlorhexidine or iodine tincture skin preparation, peripheral venipuncture rather than catheter draws, and diversion devices for the first few milliliters) 9, 2 and require at least two positive blood culture sets before initiating therapy for CoNS bacteremia.